XSAT:DBP B (Sweden)
Â
B
kr
0.39
(-5.34%)
Nov 28
Business Description
Double Bond Pharmaceutical International AB
ISIN : SE0007185525
Share Class Description:
XSAT:DBP B: BCompare
Compare
Traded in other countries / regions
DBP B.Sweden IPO Date
2015-07-10Description
Double Bond Pharmaceutical International AB is a pharmaceutical company. The company develops and commercializes approaches for the treatment of cancers, infections, autoimmune diseases, and other life-threatening disorders.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.53 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | -2.25 | |||||
| Beneish M-Score | -14.86 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -14 | |||||
| 3-Year EBITDA Growth Rate | 18.9 | |||||
| 3-Year EPS without NRI Growth Rate | 25.1 | |||||
| 3-Year Book Growth Rate | -44.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 59 | |||||
| 9-Day RSI | 59.65 | |||||
| 14-Day RSI | 58.15 | |||||
| 6-1 Month Momentum % | -34.29 | |||||
| 12-1 Month Momentum % | 0.94 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.12 | |||||
| Quick Ratio | 1.12 | |||||
| Cash Ratio | 0.84 | |||||
| Days Sales Outstanding | 19.27 | |||||
| Days Payable | 26.93 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -22.1 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -111.91 | |||||
| Operating Margin % | -804.75 | |||||
| Net Margin % | -1394.34 | |||||
| FCF Margin % | 1043.13 | |||||
| ROE % | -193.64 | |||||
| ROA % | -137.11 | |||||
| ROIC % | -95.45 | |||||
| ROC (Joel Greenblatt) % | -9991.57 | |||||
| ROCE % | -191.52 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 30.01 | |||||
| PB Ratio | 11.14 | |||||
| Price-to-Tangible-Book | 13 | |||||
| Price-to-Free-Cash-Flow | 2.96 | |||||
| Price-to-Operating-Cash-Flow | 2.96 | |||||
| EV-to-EBIT | -2.36 | |||||
| EV-to-Forward-EBIT | -3.3 | |||||
| EV-to-EBITDA | -2.38 | |||||
| EV-to-Revenue | 32.43 | |||||
| EV-to-Forward-Revenue | 23.01 | |||||
| EV-to-FCF | 2.75 | |||||
| Earnings Yield (Greenblatt) % | -42.52 | |||||
| FCF Yield % | 29.99 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Double Bond Pharmaceutical International AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 1.201 | ||
| EPS (TTM) (kr) | -0.174 | ||
| Beta | 0 | ||
| Volatility % | 106.95 | ||
| 14-Day RSI | 58.15 | ||
| 14-Day ATR (kr) | 0.057626 | ||
| 20-Day SMA (kr) | 0.3521 | ||
| 12-1 Month Momentum % | 0.94 | ||
| 52-Week Range (kr) | 0.257 - 0.99 | ||
| Shares Outstanding (Mil) | 107.12 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Double Bond Pharmaceutical International AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Double Bond Pharmaceutical International AB Stock Events
| Event | Date | Price(kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
Double Bond Pharmaceutical International AB Frequently Asked Questions
What is Double Bond Pharmaceutical International AB(XSAT:DBP B)'s stock price today?
The current price of XSAT:DBP B is kr0.39. The 52 week high of XSAT:DBP B is kr0.99 and 52 week low is kr0.26.
When is next earnings date of Double Bond Pharmaceutical International AB(XSAT:DBP B)?
The next earnings date of Double Bond Pharmaceutical International AB(XSAT:DBP B) is 2025-02-27 Est..
Does Double Bond Pharmaceutical International AB(XSAT:DBP B) pay dividends? If so, how much?
Double Bond Pharmaceutical International AB(XSAT:DBP B) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers